Julius Baer Group
VC Fund
Zürich, Switzerland
Julius Baer Group is a VC fund in Zürich focused on Financial Services and Banking. Julius Bär Group Ltd. is a Swiss private banking group. The firm concentrates on the needs of individual clients, family offices, and independent asset managers
- Total investments:
- 7
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Julius Baer Group invests in
Stages Julius Baer Group invests in
Countries Julius Baer Group invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
|
|||
|
Damien Crommie
|
|||
|
|
|||
|
Harry J.F. Bloomfield
|
|||
|
|
|||
| See all 8 contacts → | |||
Investment Focus
Industry
- Financial Services 3 (43%)
- Banking 2 (29%)
- Health Care 2 (29%)
- Finance 1 (14%)
- Lending 1 (14%)
Stage
- Series A 2 (29%)
- Series B 2 (29%)
- Pre-Seed 1 (14%)
- Series C 1 (14%)
- Series G 1 (14%)
Country
- United States 2 (29%)
- United Kingdom 2 (29%)
- Israel 1 (14%)
- Switzerland 1 (14%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Daniel Borel
Member of the Board of Directors
|
Member of the Board of Directors | Total investments: 0 | Find email | |
|
Damien Crommie
Executive Director
|
Executive Director | Total investments: 0 | Find email | |
|
Dieter Enkelmann
Chief Financial Officer
|
Chief Financial Officer | Total investments: 0 | Find email | |
|
Harry J.F. Bloomfield
Canadian partner
|
Canadian partner | Total investments: 0 | Find email | |
|
Jeremy Cohen
Finance Transformation
|
Finance Transformation | Total investments: 0 | Find email | |
| See all 8 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
|
Firenze aims to expand financial services by extending investment-backed lending to a wider audience, recognizing its importance in wealth creation and preservation. The founding team aims to democratize Lombard lending, making it accessible to all, while focusing on mass affluent clients. | $938.7K / Pre-Seed / Dec 31, 2024 | |
|
|
FDB is Israel's first digital bank to incorporate artificial intelligence. | $62M / Series B / Feb 05, 2023 | |
|
|
SEBA Bank is a cryptocurrency company that provides a seamless, secure, and easy-to-use bridge between digital and traditional assets. Its services allow customers to secure, trade, and manage cryptocurrencies, digital assets, and conventional securities all in one place. It also allows customers and clients to have access to convenient andtransparent investment solutions for their crypto and traditional assets.The company was founded in 2018 and is based in Zug, Zug, Switzerland. | $120.3M / Series C / Jan 12, 2022 | |
|
|
FDB is Israel's first digital bank to incorporate artificial intelligence. | $120M / Series A / Dec 14, 2021 | |
|
|
dnaNUDGE aims to nudge people towards a better lifestyle based on their DNA. | $60M / Series A / Aug 19, 2021 | |
|
|
Moderna Therapeutics is a biotechnology company that develops messenger RNA therapeutics. Every cell in the body uses mRNA to provide real-time instructions to make the proteins necessary to drive all aspects of biology, including in human health and disease. It provides in vivo drug modality that produces human proteins or antibodies insidepatient cells. Moderna Therapeutics also develops various patent applications with various claims ranging from novel nucleotide chemistries to specific drug compositions. It focuses on disease areas, such as inherited genetic disorders, hemophilia, and blood factors, and oncology. Moderna Therapeutics in 2010 and is headquartered in Cambridge in Massachusetts. It has strategic option agreements with AstraZeneca and Alexion Pharmaceuticals and strategic collaborations with Karolinska Institutet, Institut Pasteur, Karolinska University Hospital, and Merck. | $500M / Series G / Feb 01, 2018 | |
|
|
At apps4biz.com™, ease-of-use and affordability are Their passion. They understand that a small business does not have the resources to learn, implement and fully utilize complex systems. apps4biz.com solutions enable you to quickly take advantage of your investment. And, you can easily tailor the apps4biz.com solution to accommodate your businessnow, and as your company grows. | $8M / Series B / Jun 08, 2000 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Julius Baer Group invest in?
Julius Baer Group invests primarily in Financial Services, Banking and Health Care startups, most often at Series A and Series B stage. Most of the 7 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Julius Baer Group?
Public channels for Julius Baer Group include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Julius Baer Group?
The team at Julius Baer Group includes Daniel Borel (Member of the Board of Directors), Damien Crommie (Executive Director) and Dieter Enkelmann (Chief Financial Officer), among 8 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!